Alzheimer's disease & dementia

The two obstacles that are holding back Alzheimer's research

Thirty years ago, scientists began to unlock the mysteries regarding the cause of Alzheimer's disease. This knowledge ushered in an era of great enthusiasm that scientists could develop new therapies to either prevent Alzheimer's ...

Medications

US group seeks to block Gilead drug patent in India

A US-based patient rights group said Saturday it has sought to block a bid by California-based Gilead Sciences to obtain an Indian patent for a potentially blockbuster drug to treat hepatitis C.

Genetics

3Qs: Supreme Court rules human genes can't be patented

The U.S. Supreme Court ruled in a unanimous decision Thursday that naturally occurring human genes can't be patented. The case centered on Myriad Genetics Inc.'s patents on popular breast and ovarian cancer tests. These tests ...

Genetics

Patenting the human genome

Can human genes be patented? That was the question posed by Alan J. Snyder, vice president and associate provost for research and graduate studies at Lehigh, and Lee Kaplan, scientific director of cellular and molecular genetics ...

Genetics

US top court to hear case on gene patents

The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.

Genetics

Are human genes patentable?

(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, are isolated human ...

Medications

India's top court to deliver Novartis judgment

India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies that say they ...

page 1 from 2